Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Castillo

Showing results (1071-1080 of 1,342) with videos related to

Pageof 135
Sort By:
Journal of Science and Medicine in Sport|May 11, 2010
Secular trends in health-related physical fitness in Spanish adolescents: the AVENA and HELENA studiesD Moliner-Urdiales, J R Ruiz, F B Ortega, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 23, 2023
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020S García-Fernández, J Calvo, E Cercenado, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 31, 2020
Longitudinal evaluation of motor function in patients who underwent prenatal or postnatal neural tube defect repairR Corroenne, M Yepez, M Pyarali, et al.
Blood Advances|December 29, 2021
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapyJorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, et al.
Blood|May 5, 2016
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinibGuang Yang, Sara J Buhrlage, Li Tan, et al.
Transplantation Proceedings|May 4, 2005
Liver transplantation at the Cuban Center for Medical and Surgical ResearchL González, A Abdo, O López, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
British Journal of Haematology|July 6, 2016
Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström MacroglobulinaemiaJorge J Castillo, Ramon Garcia-Sanz, Evdoxia Hatjiharissi, et al.
British Journal of Haematology|September 6, 2018
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemiaJoshua N Gustine, Nicholas Tsakmaklis, Maria G Demos, et al.
The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.
Pageof 135

Showing results (1071-1080 of 1,342) with videos related to

Sort By:
Pageof 135
Journal of Science and Medicine in Sport|May 11, 2010
Secular trends in health-related physical fitness in Spanish adolescents: the AVENA and HELENA studiesD Moliner-Urdiales, J R Ruiz, F B Ortega, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|March 23, 2023
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020S García-Fernández, J Calvo, E Cercenado, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|July 31, 2020
Longitudinal evaluation of motor function in patients who underwent prenatal or postnatal neural tube defect repairR Corroenne, M Yepez, M Pyarali, et al.
Blood Advances|December 29, 2021
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapyJorge J Castillo, Shayna R Sarosiek, Joshua N Gustine, et al.
Blood|May 5, 2016
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinibGuang Yang, Sara J Buhrlage, Li Tan, et al.
Transplantation Proceedings|May 4, 2005
Liver transplantation at the Cuban Center for Medical and Surgical ResearchL González, A Abdo, O López, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
British Journal of Haematology|July 6, 2016
Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström MacroglobulinaemiaJorge J Castillo, Ramon Garcia-Sanz, Evdoxia Hatjiharissi, et al.
British Journal of Haematology|September 6, 2018
TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenström macroglobulinaemiaJoshua N Gustine, Nicholas Tsakmaklis, Maria G Demos, et al.
The Lancet. Infectious Diseases|March 26, 2023
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trialGail B Cross, Intan P Sari, Cissy Kityo, et al.
Pageof 135